SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefanie B. Marquez, Kenneth W. Thompson, Li Lu, David Reisman, Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation, Frontiers in Oncology, 2015, 4,

    CrossRef

  2. 2
    Christine M. Fillmore, Chunxiao Xu, Pooja T. Desai, Joanne M. Berry, Samuel P. Rowbotham, Yi-Jang Lin, Haikuo Zhang, Victor E. Marquez, Peter S. Hammerman, Kwok-Kin Wong, Carla F. Kim, EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors, Nature, 2015,

    CrossRef

  3. 3
    Simone T. Sredni, Tadanori Tomita, Rhabdoid Tumor Predisposition Syndrome, Pediatric and Developmental Pathology, 2015, 18, 1, 49

    CrossRef

  4. 4
    Kazuyoshi Kobayashi, Kouhei Sakurai, Hiroaki Hiramatsu, Ken-ichi Inada, Kazuya Shiogama, Shinya Nakamura, Fumiko Suemasa, Kyosuke Kobayashi, Seiya Imoto, Takeshi Haraguchi, Hiroaki Ito, Aya Ishizaka, Yutaka Tsutsumi, Hideo Iba, The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines, Scientific Reports, 2015, 5, 8428

    CrossRef

  5. 5
    Yixing Han, Jianke Ren, Weishi Yu, Minoru Terashima, Kathrin Muegge, Epigenetics and Dermatology, 2015,

    CrossRef

  6. 6
    Laia Simó-Riudalbas, Manel Esteller, Cancer genomics identifies disrupted epigenetic genes, Human Genetics, 2014, 133, 6, 713

    CrossRef

  7. 7
    David M. Roy, Logan A. Walsh, Timothy A. Chan, Driver mutations of cancer epigenomes, Protein & Cell, 2014, 5, 4, 265

    CrossRef

  8. 8
    Reem Ibrahim, Daisuke Matsubara, Wael Osman, Teppei Morikawa, Akiteru Goto, Shigeki Morita, Shumpei Ishikawa, Hiroyuki Aburatani, Daiya Takai, Jun Nakajima, Masashi Fukayama, Toshiro Niki, Yoshinori Murakami, Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition, Human Pathology, 2014, 45, 7, 1397

    CrossRef

  9. 9
    G. R. Hoffman, R. Rahal, F. Buxton, K. Xiang, G. McAllister, E. Frias, L. Bagdasarian, J. Huber, A. Lindeman, D. Chen, R. Romero, N. Ramadan, T. Phadke, K. Haas, M. Jaskelioff, B. G. Wilson, M. J. Meyer, V. Saenz-Vash, H. Zhai, V. E. Myer, J. A. Porter, N. Keen, M. E. McLaughlin, C. Mickanin, C. W. M. Roberts, F. Stegmeier, Z. Jagani, Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers, Proceedings of the National Academy of Sciences, 2014, 111, 8, 3128

    CrossRef

  10. 10
    Leora Witkowski, Jian Carrot-Zhang, Steffen Albrecht, Somayyeh Fahiminiya, Nancy Hamel, Eva Tomiak, David Grynspan, Emmanouil Saloustros, Javad Nadaf, Barbara Rivera, Catherine Gilpin, Ester Castellsagué, Rachel Silva-Smith, François Plourde, Mona Wu, Avi Saskin, Madeleine Arseneault, Rouzan G Karabakhtsian, Elizabeth A Reilly, Frederick R Ueland, Anna Margiolaki, Kitty Pavlakis, Sharon M Castellino, Janez Lamovec, Helen J Mackay, Lawrence M Roth, Thomas M Ulbright, Tracey A Bender, Vassilis Georgoulias, Michel Longy, Andrew Berchuck, Marc Tischkowitz, Inga Nagel, Reiner Siebert, Colin J R Stewart, Jocelyne Arseneau, W Glenn McCluggage, Blaise A Clarke, Yasser Riazalhosseini, Martin Hasselblatt, Jacek Majewski, William D Foulkes, Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type, Nature Genetics, 2014, 46, 5, 438

    CrossRef

  11. 11
    Vicente Morales-Oyarvide, Mari Mino-Kenudson, High-grade lung adenocarcinomas with micropapillary and/or solid patterns, Current Opinion in Pulmonary Medicine, 2014, 20, 4, 317

    CrossRef

  12. 12
    Daisuke Matsubara, Yuka Kishaba, Taichiro Yoshimoto, Yuji Sakuma, Takashi Sakatani, Tomoko Tamura, Shunsuke Endo, Yukihiko Sugiyama, Yoshinori Murakami, Toshiro Niki, Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer, Pathology International, 2014, 64, 11